1 / 40

Drug metabolism

Drug metabolism. Dr.S.O. Ogundele. Introduction. Drug metabolism is a process transforming drugs to a more water soluble metabolite within the body Most drugs are hydrophobic Drug metabolism results in the following Prevention of accumulation of drug within the body

mary-beard
Download Presentation

Drug metabolism

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Drug metabolism Dr.S.O. Ogundele

  2. Introduction • Drug metabolism is a process transforming drugs to a more water soluble metabolite within the body • Most drugs are hydrophobic • Drug metabolism results in the following • Prevention of accumulation of drug within the body • Conversion of most drugs to a less active metabolite

  3. Introduction • Prodrugs are converted to a more active form by the process of metabolism e.g. • Prednisone • Primaquine • Proguanil • Methyldopa • Disulphiram • Azathioprin

  4. Sites of metabolism Extrahepatic microsomal enzymes (oxidation, conjugation) Hepatic microsomal enzymes (oxidation, conjugation) Hepatic non-microsomal enzymes (acetylation, sulfation,GSH, alcohol/aldehyde dehydrogenase, hydrolysis, ox/red)

  5. Sites of metabolism • Liver is the principal organ for drug metabolism • Other tissues with considerable activities include • Lungs • Skin • GIT • kidney

  6. Sites of metabolism • Metabolising enzymes are located in • Smooth endoplasmic reticulum • Mitochondria • Cytosol • Plasma membrane

  7. First pass effect • First pass effect is the metabolism of orally taken drugs before they get into systemic circulation • Site of first pass metabolism include • Intestinal mucosa • CYP Enzymes • P-Glycoprotein • Liver • CYP Enzymes

  8. Oral route of drug intake1st pass metabolism

  9. IV route

  10. Drugs affected by 1st pass metabolism • Examples of such drugs include • Aldosterone • Morphine • Cyclosporine • Nortriptyline • Isoproterenol • Organic nitrates • Lidocaine • Propranolol

  11. Phase I metabolism • Phase I (functionalization reaction phase): • This involves conversion of lipophylic molecules to a more polar molecule by introduction or unmasking of a polar functional group • E.g of Phase I reaction: • Hydroxylation (Aliphatic or aromatic) • Dealkylation (N-,O-, S-) • Oxidation (N- or S-oxidation) • Deamination • Hydrolysis, hydration • Dehalogenation

  12. Phase I metabolism • Phase I metabolism results in changes in biological activity of most drugs leading to • Increase in activity • Decreased in activity • Sometimes there is no change

  13. Phase II metabolism • Conjugation reaction takes place during phase II of metabolism • An endogenous substrate is added to the established functional group from phase I to form a highly polar metabolite

  14. Phase II metabolism • Conjugation reactions include: • Glucuronidation • Sulfation • Methylation • Acetylation • Condesation • Amino acid conjugation • In most cases it results in detoxification

  15. Process of Phase I metabolism • The smooth ER of the liver contain an important enzyme known as the mixed function oxidase (MFO) or monooxygenase • Activities of MFO require both a reducing agent (NADPH) and a molecular oxygen (reaction is an oxidative-reductive) • In a typical reaction one mol of oxygen is consumed, one atom of oxygen appears in the product and the other forms water

  16. Process of Phase I metabolism • One of the enzymes involved in this process is NADPH-cyp reductase • NADPH-cyp reductase is a flavoprotein • One molecule of this enzyme contain 1 mole each of flavine mononucleotide (FMN) and flavine adenine dinucleotide (FAD) • The cytochrome serves to accept electron

  17. Process of Phase I metabolism • The second enzyme is an haemoprotein Cyt P-450, it serves as the terminal oxidase • In its reduce form (ferrous) it binds carbon monoxide and absorbs light max at 450nm (this is why it is so named) • Compared to the reductase this enzyme is abundant and its action is the rate limiting step in hepatic oxidation • It is an isoenzyme

  18. Electron flow in microsomal drug oxidizing system Drug NADP+ Fe+3 CYP CYP R-Ase Drug PC OH NADPH Fe+3 CYP CO CO Fe+2 Drug CYP CYP-Fe+2 OH hu Drug Drug O2 Fe+2 CYP H2O O2 Drug 2H+ e- Drug e-

  19. Consequences of phase I reaction • Oxidative reaction can results in any of the following • Formation of an inactive polar metabolite • Phenobarbital • Formation of an active metabolite • Methyl dopa, prednisone • Formation of a toxic metabolite • Acetaminophen – NAPQI

  20. CYP Families • Multiple CYP gene families have been identified in humans • They are categorised according to their protein sequence homology • Most of the drug metabolizing enzymes are in CYP 1, 2, & 3 families • CYPs have molecular weights of 45-60 kDa

  21. CYP Families • Frequently two or more enzymes can catalyze the same type of oxidation, indicating redundant and broad substrate specificity • CYP3A4 is very common to metabolism of many drugs • Its presence in the GI tract is responsible for poor oral availability of many drugs

  22. CYP Nomenclature • Families - CYP plus arabic numeral >40% homology of amino acid sequence, eg.CYP1 • Subfamily - 40-55% homology of amino acid sequence; eg. CYP1A • Subfamily - additional arabic numeral when more than 1 subfamily has been identified; eg. CYP1A2 • Italics indicate gene CYP1A2 • Regular font indicate enzyme

  23. ROLE OF CYP ENZYMES IN HEPATIC DRUG METABOLISM RELATIVE HEPATIC CONTENT OF CYP ENZYMES % DRUGS METABOLIZED BY CYP ENZYMES A. Atkinson, 2005

  24. Participation of the CYP Enzymes in Metabolism of Some Clinically Important Drugs Adapted from: S. Rendic Drug Metab Rev 34: 83-448, 2002

  25. Factors Influencing Activity and Level of CYP Enzymes Red indicates enzymes important in drug metabolism Adapted from: S. Rendic Drug Metab Rev 34: 83-448, 2002

  26. Phase II Metabolism • This is a conjugation reaction • Major Conjugation Reactions are • Glucuronidation (high capacity) • Substrates include phenol, alcohol, sulfonamide • Drugs in this group include, morphine, digoxin, diazepan

  27. Phase II Metabolism • Sulfation (low capacity) • e.g. methyl dopa • Acetylation (variable capacity) • Substrates are amines e.g. Procainamide, Isoniazid • Other Conjugation Reactions: • O-Methylation • S-Methylation • Amino Acid Conjugation (glycine, taurine, glutathione) • Many conjugation enzymes exhibit polymorphism

  28. Conjugation Reactions Glucuronidation Liver has several soluble UDP-Gluc-transferases

  29. Conjugation ReactionsAcetylation E.g.: Procainamide, isoniazid, sulfanilimide, histamine NAT enzyme is found in many tissues, including liver

  30. Non-CYP drug oxidations • Monoamine Oxidase (MAO), Diamine Oxidase (DAO) • MAO (mitochondrial) oxidatively deaminates endogenous substrates including neurotransmitters (dopamine, serotonin, norepinephrine, epinephrine) • DAO substrates include histamine and polyamines

  31. Non-CYP drug oxidations • Alcohol & Aldehyde Dehydrogenase • Non-specific enzymes found in soluble fraction of liver • Responsible for ethanol metabolism • Xanthine Oxidase • Converts hypoxanthine to xanthine, and then to uric acid • Drug substrates include 6-mercaptopurine • Allopurinol is a substrate and inhibitor of xanthine oxidase; delays metabolism of other substrates • Effective for treatment of gout

  32. Non-CYP drug oxidations • Flavin Monooxygenases • Family of enzymes that catalyze oxygenation of nitrogen, phosphorus, sulfur – particularly facile formation of N-oxides • Different FMO isoforms have been isolated from liver, lung • Complete structures has been defined • Require molecular oxygen, NADPH, flavin adenosine dinucleotide (FAD)

  33. Non-CYP drug oxidations • Single point (loose) enzyme-substrate contact with reactive hydroperoxyflavin monoxoygenating agent • FMOs are heat labile and metal-free, unlike CYPs • Factors affecting FMOs (diet, drugs, sex) not as highly studied as CYPs

  34. CYP Inhibition • Inhibition of CYP is usually by competitive binding to the active site. • Onset and offset dependent on the half-life and time to steady-state of the inhibitor. e.g Fluoxetine/CYP2D6Ritonavir/CYP3A4 • Time to maximum interaction effect dependent on time required for substrate drug to reach new steady-state • Mechanism is by enzyme inactivation • Grapefruit juice and intestinal CYP3A content

  35. Common CYP inhibitors • Cimetidine (various) • Erythromycin, clarithromycin (3A4) • Ketoconazole, itraconazole (3A4) • HIV protease inhibitors (ritonavir) • Fluoxetine, paroxetine (CYP2D6) • Nefazodone (CYP3A4) • Grapefruit Juice (intestinal CYP3A4 only)

  36. CYP Induction • Common suspects (RRCPPNST) • Rifampin • Rifabutin • Carbamazepine • Phenobarbital • Phenytoin • Nevirapine, efavirenz • St. John’s wort • Troglitazone, pioglitazone

  37. Effects on induction of drug metabolism • Results in reduction of plasma concentration of substrate drugs • Risk of therapeutic failure • Removal of inducer may lead to toxic concentrations of substrate • Induction may lead to formation of toxic metabolite

  38. Note • Sometimes Phase II reaction may precede phase I reaction e.g acetylation of INH • If drug metabolite is sufficiently polar enough, they may be excreted after phase I reaction • Examples of pro-drugs (metabolism results in formation of a more active metabolite) include the following: prednisone, primaquine, proguanil, methyldopa, disulphiram, azathioprin

  39. Kinetics of metabolism • 1st order • Rate of metabolism depends on the concentration of the substrate, a constant proportion of drug is metabolised per unit time • Zero order • Constant amount of drug is metabolised irrespective of drug concentration

  40. Conclusion Thank you!

More Related